1. 雒建斌 中国 清华大学 中国科学院院士 Recent application of Raman spectroscopy in tumor diagnosis: from conventional methods to artificial..
2. Owen N. Witte 美国 University of California, Los Angeles 2003美国医学院院士;1997美国科学院院士 Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutami..
3. 刘刚 中国 厦门大学 NIR-II light triggered burst-release cascade nanoreactor for precise cancer chemotherapy
4. 崔红娟 中国 西南大学 OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signalin..
5. Beliveau, Richard 加拿大 University of QUEBEC Sudocetaxel Zendusortide (TH1902) triggers the cGAS/STING pathway and potentiates anti-PD-L1 immune-..
6. Alan,Pollack 美国 University of Miami Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistan..
7. Daunert, Sylvia 美国 University of Miami Activation of Stimulator of Interferon Genes (STING): Promising Strategy to Overcome Immune Resistan..
8. Yohann,Loriot 法国 UNIVERSITE PARIS SACLAY FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
9. Masaru,Katoh 日本 National Cancer Center Research Institute FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
10. Gautam,Sethi 新加坡 National University of Singapore Molecular panorama of therapy resistance in prostate cancer: a pre-clinical and bioinformatics analy..
11. 张力 中国 中山大学 The BCL-2 inhibitor APG-2575 resets tumor-associated macrophages toward the M1 phenotype, promoting ..
12. Paul R,Thompson 美国 University of MASSACHUSETTS Inhibiting MEK1 R189 citrullination enhances the chemosensitivity of docetaxel to multiple tumour ce..
13. Sara,Gandini 意大利 European Institute oncology Investigating Nutritional and Inflammatory Status as Predictive Biomarkers in Oligoreccurent Prostat..
14. Barbara Alicja,Jereczek-Fossa 意大利 University of Milan Investigating Nutritional and Inflammatory Status as Predictive Biomarkers in Oligoreccurent Prostat..
15. Susanna C,Larsson 瑞典 Uppsala University Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating hum..
16. Malcolm G,Dunlop 英国 University of EDINBURGH Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating hum..
17. Evropi,Theodoratou 英国 University of EDINBURGH Identification of novel protein biomarkers and drug targets for colorectal cancer by integrating hum..
18. Phillip K,Darcy 澳大利亚 Peter MacCallum Cancer Center Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human pro..
19. Joseph A,Trapani 澳大利亚 Peter MacCallum Cancer Center Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human pro..
20. Gail P,Risbridger 澳大利亚 Monash University Low-dose carboplatin modifies the tumor microenvironment to augment CAR T cell efficacy in human pro..